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Abstract
Background: Gprc5b, a retinoic acid-inducible orphan G protein–coupled receptor (GPCR), is a member of the group C
metabotropic glutamate receptor family proteins possibly involved in non-canonical Wnt signaling. Many GPCR transcripts
are alternatively spliced, which diversifies this class of proteins in their cell- and tissue-specific signaling, regulatory and/or
pharmacological properties. We previously generated p97FE65 isoform-specific knockout mice that showed learning/
memory deficits. In this study, we further characterized the 97FE65 null mice using cDNA microarray and RT-PCR analyses.
Methodology/Principal Findings: We discovered a novel brain-specific C-terminal splice variant of Gprc5b, Gprc5b_v2,
which was differentially expressed in p97FE65 wild type and null mouse brains. The null mice were generated in 129/Sv ES
cells, and backcrossed to C57Bl/6J for ten generations. We found that expression of Gprc5b_v2 mRNA in the brains of
p97FE65 null mice was dramatically down-regulated (more than 20 fold) compared to their wild type littermates. However,
expression profiles of Gprc5b variants and SNP analysis surrounding the FE65 locus suggest that the down-regulation is
unlikely due to the altered FE65 function, but rather is caused by gene retention from the 129/Sv ES cells. Consistently, in
contrast to ubiquitously expressed Gprc5b_v1, Gprc5b_v2 was predominantly expressed in the brain tissues of C57Bl/6J
mice. The alternative splicing of the 39 terminal exon also altered the protein coding sequences, giving rise to the
characteristic C-termini. Levels of Gprc5b_v2 mRNA were increased during neuronal maturation, paralleling the expression
of synaptic proteins. Overexpression of both Gprc5b variants stimulated neurite-like outgrowth in a neuroblastoma cell line.
Conclusions/Significance: Our results suggest that Gprc5b-v2 may play a role during brain maturation and in matured
brain, possibly through the regulation of neuronal morphology and protein-protein interaction. This study also highlights
the fact that unexpected gene retention following repeated backcrosses can lead to important biological consequences.
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Introduction
G protein-coupled receptors (GPCRs), characterized by seven
transmembrane domains, constitute important classes of evolution-
arily conserved receptor proteins. They are also the most popular
pharmaceutical targets due to their key roles in cell signaling [1].
Gprc5b, also known as retinoic acid inducible gene 2 (Raig2), is a
member of the Raig subfamily of type 3 (family C) GPCRs. These
proteins share homologies with the metabotropic glutamate
receptors (mGluRs) in their seven transmembrane domain regions
[2,3]. In addition to the Raig and mGluR subfamilies, family C also
includes GABAB,c a l c i u m - s e n s i n g ,a n dp h e r o m o n er e c e p t o r s ,a l lo f
which play significant roles in neuronal functions [4].
In addition to Gprc5b, three other Raigs have also been
identified. In contrast to other family C members, the Raig
receptors feature short amino termini more reminiscent of groups
A and B of GPCRs [1,3]. Although ligands have yet to be
identified for any member of this orphan GPCR subfamily,
recent evidence suggests that the Raig receptors may play a role
in Wnt signaling. All of the four Raig receptors were found as
potential Frizzled receptor-binding proteins to activate players in
the non-canonical Wnt planar cell polarity pathway [5].
Overexpression of Gprc5b was also found to stimulate intracel-
lular calcium release, possibly via activation of non-canonical
Wnt calcium signaling [6], and to recapitulate non-canonical
Wnt phenotypes observed with overexpressed Frizzled in
Xenopus embryos [7]. Gprc5b is abundantly expressed in brain,
with highest levels in the neocortex, hippocampus, and
cerebellum [3,8], although expression in peripheral tissues has
also been observed [2,3]. In brain, strong Gprc5b immunoreac-
tivity was found in the cytoplasm of the cell body in pyramidal
neurons, granule cells and Purkinje neurons; weak immunoreac-
tivity was also detected in apical dendrites and neurites, and in
astrocytes and oligodendrocytes [8].
PLoS ONE | www.plosone.org 1 April 2010 | Volume 5 | Issue 4 | e10351FE65 is an adaptor protein that may influence the pathogenesis
of Alzheimer Disease via its strong interaction with the
intracellular tail of the beta-amyloid precursor protein (APP) [9].
FE65 may also play an important role in modulation of nuclear
signaling [10,11]. In searching for genes targeted by the FE65-
APP pathway using cDNA microarray analysis, we discovered a
novel C-terminal splice variant of Gprc5b, Gprc5b_v2, which was
significantly down-regulated in brains of p97FE65 (the full-length
FE65) isoform-specific null mice, when compared with their wild
type littermates. Further analyses revealed that the novel splice
variant might be important for neuron/brain maturation.
However, our evidence indicates that the differential splicing of
Gprc5b was unlikely to have resulted from altered FE65 function,
but instead was due to retained loci from 129/Sv ES cells that
flank the FE65 locus.
Results
Discovery of a novel, brain-enriched Gprc5b splice
variant that is differentially expressed in p97FE65 null vs.
p97FE65 wild type mice
Full-length FE65 (p97FE65) is a 97 kDa adaptor protein that
has been shown to function as a transcriptional activator in the
FE65/APP nuclear signaling pathway [10,11]. In order to identify
potential FE65 transcriptional targets, we performed cDNA
microarray experiments on p97FE65 null mice generated by our
laboratory [12]. The p97FE65 null clones were initially generated
in 129/Sv-derived R1 ES cells and then the targeted clones were
injected into C57Bl/6J blastocysts. At the time of microarray
analysis, the mice had been back-crossed to C57Bl/6J mice for ten
generations. We have previously shown that these mice exhibit
deficits in learning and memory [12]. Gene expression profiles of
the individual cerebral cortex of five littermate pairs of male
p97FE65 null and p97FE65 wild type mice at six months of age
were compared by microarray analysis with Affymetrix mouse
430A 2.0 chips (see Methods S1). Expression differences for all but
one gene, Gprc5b (probe set 1451411_at), were less than 2-fold,
with the false discovery rate predicted for all genes at
0.55.q.0.22 (Tables S1 and S2). The results are consistent with
previous observations that gene expression differences in brain
tissues measured by microarrays are usually small [13,14],
probably due to the cellular heterogeneity of brain tissues. Among
the differentially expressed genes, 15 genes had greater than 1.4-
fold differences in expression level (p,0.004), with 8 up-regulated,
including Gprc5b (Table S1), and 7 down-regulated in p97FE65
null mice (Table S2).
Our further study was focused on Gprc5b because of its high
differential expressions. Although real-time qPCR with pre-
designed Assays-on-Demand primer/probe sets (Applied Biosys-
tems, Foster City, CA) failed to confirm the differential expression
of Gprc5b, we noticed that the sequences amplified by real-time
qPCR did not overlap with those targeted by microarray probe
sets (Fig. 1A), which could potentially have contributed to the
discrepancy between microarray and qPCR results. We therefore
employed semi-quantitative RT-PCR using primers that amplify
the exact regions detected in microarray probe set 1451411_at
(Fig. 1A). By this approach, we found a substantial up-regulation
(up to 21.6- fold, determined by densitometry analysis) in Gprc5b
in forebrains of p97FE65 null mice compared to wild type mice,
using primer sets (C/c and B/d) that are overlapped with
microarray probe set 1451411_at (Fig. 1A) (p,0.00001;
Figs. 1B–C, upper panels). In contrast, expression of Glyceralde-
hyde-3-phosphate dehydrogenase (Gapdh) was not changed
(Fig. 1B, bottom panel); no differential expressions of Gprc5b in
the same samples were detected when a downstream region was
analyzed by either microarray (probe set 1424613_at) (Fig. 1A) or
RT-PCR analysis (Fig. 1B, middle panels). The results indicated that
(1) an alternative splicing event might occur in the 39 region of the
Gprc5b transcript; (2) the alternative splicing might differ between
p97FE65 null and wild type mouse brains; (3) the region targeted
by microarray probe set 1451411_at and overlapped with primer
set B/d (Fig. 1A) might be spliced out in p97FE65 wild type mouse
brains.
Further experiments confirmed the assumptions. RT-PCR
analysis with primers B/f identified a PCR product (,750 bp) in
p97FE65 wild type brains (Fig. 1C, middle panel); the fragment was
barely detectable in p97FE65 null mice. As the PCR product was
considerably smaller than 2.7 kb, the expected size from the
Gprc5b transcript reference (NM_022420), we reasoned that a
2 kb fragment in Gprc5b mRNA was spliced out in p97FE65 wild
type brains. Searching sequence databases, we found an EST
sequence (CJ049931) from a cDNA library derived from C57Bl/6J
mouse medulla oblongata that also suggested similar alternative
splicing in this region. Both Gprc5b RT-PCR products (750 bp
and 1.86 kb) depicted in Fig. 1C were purified and sequenced.
The sequencing results confirmed that the RT-PCR products
represented two splice variants of the Gprc5b gene, due to use of
alternative 39 acceptor sites for the terminal exon (exon 4). The
variant predominantly expressed in p97FE65 wild type brains
contained a truncated exon 4, lacking approximately 2 kb of its 59
portion compared to the reference (NM_022420). The other
variant, abundantly expressed in p97FE65 null mouse brains, was
identical to the Gprc5b reference. In accordance with the system
adopted by the Mouse and Human Genome Nomenclature
Committees, we have chosen to name the Gprc5b transcript
reference sequence (NM_022420) as Gprc5b_v1, and the novel
splice variant, predominant in p97FE65 wild type (i.e. C57Bl/6J)
brain, as Gprc5b_v2. The alternative splicing also altered the
protein coding sequences at the extreme C-termini, giving rise to
the characteristic 14 amino acid residues in Gprc5b_v1, and 15
residues in Gprc5b_v2 (Fig. 1D; also see Discussion Section).
We examined expressions of the two splice variants in various
tissues of C57Bl/6J mice. Interestingly, Gprc5b_v2, shown to have
been predominantly expressed in C57Bl/6J brain, was not
expressed (or expressed at below detectable levels) in other tissues
(Fig. 2A, middle panel). Consistent with the previous evidence [2,3],
Gprc5b_v1 was detected in all examined tissues of C57Bl/6J mice,
including brain, embryo, testes, lung, spleen, kidney, and intestine
(Fig. 2A, upper panel). In addition, Gprc5b_v2 was also strongly
expressed in human middle frontal cortex, but not in caudate
nucleus and several peripheral tissues examined (testes, skeletal
muscle, and small intestine) (Fig. 2B). These observations suggest
that Gprc5b_v2 may play a special functional role(s) in brain.
The splice variation found in p97FE65 null mice is due to
retention of a 129/Sv genomic sequence: the ‘‘flanking
gene problem’’
Interestingly, Gprc5b resides on mouse chromosome 7, where
the FE65 gene is located. The coincidence raised our concern that
the differential expressions of Gprc5b splice variants in the brains
of p97FE65 null vs. wild type mice might not be due to altered
FE65 function, but was rather, despite the extensive backcrossing
to C57Bl/6J, due to the retention of genomic sequences flanking
the FE65 locus in strain 129/Sv mice (the strain of ES cells used to
generate the knockout before backcrossing to C57Bl/6J) [12].
Expressions of the Gprc5b splice variants in C57Bl/6J and 129/Sv
mice were therefore evaluated and compared. Strikingly, the
brains of 129S1/SvImJ and 129X1/SvJ mice also predominantly
Gprc5b Splice Variants
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reinforced our hypothesis that retention of 129/Sv ES cell-derived
genes flanking the FE65 locus influenced the pattern of alternative
splicing of Gprc5b. To further investigate this possibility, we
searched for mouse single nucleotide polymorphisms (SNPs) in the
Mouse Phenome Database (http://www.jax.org/phenome). We
found unique SNPs in the Gprc5b gene that are differentially
present between the 129/Sv (129X1 and 129S1), and C57Bl/6J
strains. Genomic DNA sequencing across four SNP locations (SNP
IDs: rs31179950, rs31329276, rs32286710, and rs31634095)
within exon 4 of Gprc5b confirmed that the Gprc5b genomic
sequence in p97FE65 null mice matched strain 129/Sv but not
Figure 1. p97FE65 wild type and null mice express different Gprc5b splice variants in brain. A: Schematic drawing of Gprc5b transcript
and location of primers used to amplify Gprc5b by RT-PCR. Forward and reverse primers are depicted by upper and lower case letters, respectively.
Dark bars represent regions targeted by microarray probes and real-time PCR primer sets. B–C: RT-PCR analysis of Gprc5b transcripts present in
forebrains of p97FE65 wild type (+/+) and null (2/2) mice (3–12 months of age). Gapdh mRNA was amplified as control (bottom panels). B: Total
mRNA was analyzed with Gprc5b primer sets C/c (upper panel) and D/g (middle panel). C: Total mRNA was further analyzed with primer sets B/d
(upper panel) and B/f (middle panel). Primer set B/f amplified a band (,750 bp) in wild type mouse forebrains, which was smaller than the size
(,2.7 kb) predicted from the Gprc5b mRNA reference (NM_022420). We were unable to detect the predicted product (,2.7 kb) in either genotype
using the PCR parameters described in MATERIALS AND METHODS, presumably due to difficulty in amplifying the large size of the amplicon. No RT
(negative control): mRNA that was not reverse transcribed into cDNA. D: The cDNA and deduced protein sequences at the E3/E4 exon boundary for
Gprc5b_v1, the predominant splice variant expressed in 2/2 brain (and also in 129/Sv brains; see Figures 3&4), and Gprc5b_v2, the predominant
splice variant expressed in +/+ brain (and also in C56Bl/6J brains; see Figures 3&4). The protein sequences derived from the alternatively spliced E4 are
underlined. The primers used in C are noted on the mRNA diagram as reference. Asterisks and underlined nucleotides denote stop codons.
doi:10.1371/journal.pone.0010351.g001
Gprc5b Splice Variants
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differential splicing of Gprc5b observed in brains of p97FE65 null
mice and their wild type littermates resulted from ‘‘the flanking
gene problem’’ [15], and is not, therefore, indicative of an
alteration of FE65 function in our memory-impaired mice bearing
a partial knockout of FE65.
Expression of Gprc5b_v2 is developmentally regulated in
C57Bl/6J brain and cultured neurons
Expression of Gprc5b in neurons of the cortex, hippocampus
and other brain regions [8] suggests that the alternative splicing
event might be associated with some aspect of neuronal
functioning. To test this hypothesis, we examined expressions of
the two variants during primary neuron maturation in vitro, as well
as in brain development in vivo. Semi-quantitative RT-PCR
analysis showed that both C-terminal splice variants were
expressed in cultured C57Bl/6J cortical neurons (Fig. 4A).
However, expression of brain-specific Gprc5b_v2 increased with
maturation of the primary neuronal cultures: Gprc5b_v2 levels in
17-day cultures were significantly greater (17 fold, determined by
densitometry analysis) than those in 7-day cultures (p,0.05) after
normalization to levels of beta-actin (Fig. 4A, upper panel). In
contrast, Gprc5b_v1 levels remained relatively constant (p.0.05)
(Fig. 4A, 2
nd panel from top). Overall Gprc5b levels, determined with
a primer set (A/a) that amplifies a region common to both
Gprc5b_v1 and v2, showed a trend towards an increase on day 17
(1.8 fold; p=0.14) after normalization to beta-actin levels (Fig. 4A,
3
rd panel from top). This probably resulted from the increased
expression of Gprc5b_v2. Similar results were observed in
repeated assays. The results indicate that expression of Gprc5b_v2
is regulated during the course of growth and differentiation of
cultured neurons.
Consistently, we also observed up-regulated expressions of
Gprc5b_v2 during development of C57Bl/6J brains (including
forebrain, cerebral cortex, and hippocampus) from post-natal day
1 (P1) up to age 3 months (3M) (Fig. 4B–D). Levels of Gprc5b_v2
were barely detectable in brain tissues at P1 and/or P7/P8, but
then increased at P10 and P12; high levels were detected at post-
natal week 2 (P15). In forebrain, an 8-fold increase in Gprc5b_v2
levels was observed at post-natal week 2 (P15) (compared to P1)
and the levels stayed relatively constant thereafter (Fig. 4C–D). In
contrast, levels of Gprc5b_v1 remained relatively unchanged in
these mice (Fig. 4B–C, 2
nd panels from the top). Overall Gprc5b levels,
Figure 2. Expression of Gprc5b_ _v2 is enriched in brain. A. Total mRNA from C57Bl/6J mouse tissues (a 2-month old male) was amplified with
Gprc5b primer sets C/c (upper panel) and B/f (middle panel) to detect Gprc5b_v1 and _v2. Primer set B/f can theoretically detect both _v1 and _v2.
However, the Gprc5b_v1 product was rarely detected, due to its large size (,2.7 kb). B. Total mRNA from human tissues (a 72 year old male) was
amplified with Gprc5b primer set A/e to detect Gprc5b_v2. See Fig. 1A for relative positions of primers on the transcripts. Gapdh mRNA was amplified
as control (bottom panels in A and B).
doi:10.1371/journal.pone.0010351.g002
Figure 3. Mouse strain-specific expressions of Gprc5b splice
variants. Total mRNA from C57Bl/6J, 129/SvJ, and 129/SvImJ
forebrains was reverse transcribed, and then amplified with Gprc5b
primer sets B/d/f (top panel), and C/c (middle panel) to detect
Gprc5b_v1 and/or _v2. See Fig. 1A for relative positions of primers on
the transcripts. Gapdh mRNA was amplified as control (bottom panel).
No RT: mRNA that was not reverse transcribed into cDNA. Mice were




PLoS ONE | www.plosone.org 4 April 2010 | Volume 5 | Issue 4 | e10351Figure 4. Expression of Gprc5b_ _v2 is increased in maturing neurons and during postnatal brain development. A. cDNA prepared from
C57Bl/6J cortical neurons cultured for 7 days (d7) or 17 days (d17) was amplified with primer sets A/e, A/b, and A/a to detect Gprc5b_v2, Gprc5b_v1,
and a region common to both splice variants, respectively. Cortical neurons were isolated from C57Bl/6J pups at postnatal day 0 (P0). Beta-actin
mRNA was amplified as a control. B. Expressions of Gprc5b_v2, and Gprc5b_v1 in cortex and hippocampus of C57Bl/6J postnatal day 7 (P7) and day
15 (P15). Primer sets B/d/f, C/c, and A/a were used in RT-PCR to detect Gprc5b_v2, Gprc5b_v1, and a region common to both splice variants,
respectively. C. Expressions of Gprc5b_v2, and Gprc5b_v1 in forebrains of C57Bl/6J mice during brain development. cDNA prepared from C57Bl/6J
forebrains, was amplified with the same primer sets described in B. The tissues were collected from mouse pups at postnatal days 1 through 15 (P1–
P15) and from 3 month-old (3M) adult mice. D. Quantitative analysis of expressions of Gprc5b splice variants detected in C. Relative intensities of
Gprc5b_v2 (top panel of C), v1 & v2 combined (the 3
rd panel from top of C), and Gapdh (bottom panel of C) cDNA bands were determined by
densitometry analysis with ScionImage software (www.scioncorp.com). Levels of Gprc5b were normalized to those of Gapdh. The two-tailed t-test
was used for the statistical analysis (all comparisons were made to P1). Levels of Gprc5b_v1 (the 2
nd panel from top of C) were not quantified due to
its low expression. E. Expressions of Gprc5b_v1, and Gprc5b_v2 in forebrains of 129/SvJ mice during brain development. cDNA prepared from 129/
Gprc5b Splice Variants
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C, 3
rd panels from the top; Fig. 4D). The results indicate that
expression of Gprc5b_v2 is up-regulated during development of
brain. We also determined expressions of Gprc5b_v1 during
development of 129/SvJ brains (we focused on forebrain only)
from post-natal day 1 (P1) to the age of 3 months (3M) (Fig. 4E–F).
In contrast to Gprc5b_v2 in C57Bl/6J, levels of Gprc5b_v1 in
129/SvJ were clearly detected at P1, and increased at P7. High
and relatively constant levels were detected from P14 to 3M.
Dependent upon which primer sets were used, magnitudes of the
increase varied from 2 to 4 fold during 129/SvJ brain maturation
(Fig. 4F) (vs. the 8-fold increase in Gprc5b_v2 levels during
C57Bl/6J brain maturation shown in Fig. 4D). The results suggest
that despite being ubiquitously expressed [2,3], Gprc5b_v1 in
129/SvJ brain may partially complement the function of
Gprc5b_v2 in C57Bl/6J brain. This interpretation is supported
by observations with assays of neurite-like outgrowth in cultured
cells, which indicate that both variants have the potential to
enhance such outgrowth (see below).
Gprc5b splice variants enhance neurite-like outgrowth
Recent evidence has shown that Gprc5b and its homolog,
XRaig2, may play a role in non-canonical Wnt signaling [5,16], a
pathway known to impact processes involved in neuronal
development and circuit formation, including dendritic arboriza-
tion and neuronal polarity [17]. Therefore, we cloned the two
mouse Gprc5b variants for assessment of their effects on neuronal
cell morphology, starting with a human neuroblastoma cell line,
SK-N-SH, as previously described [18,19].
Gprc5b_v1 and _v2 were cloned into a bicistronic mRNA
expression vector that was designed to express green fluorescent
protein (GFP) separate from the gene of interest, via an internal
ribosomal entry site (IRES) that follows the multiple cloning site
[20]. GFP was utilized as a marker of transfected cells for
morphological assessments. Flag tags were inserted at the C-
termini to aide in expression analysis. Both tagged and untagged
constructs were utilized for morphological studies to alleviate
concerns that the tag might impact function. We noted two protein
bands of about 35 and 45 kDa expressed from both of the tagged
Gprc5b splice variants in transfected SK-N-SH cell cultures
(Fig. 5A). Proteins of similar size were also expressed from C-
terminal tagged XRaig2 mRNA injected into xenopus blastocysts
[5]. The 35 kDa bands likely represent cleavage products,
although it is also possible that they are a result of translation
from alternative translation initiation sites. Further work is needed
to confirm the putative cleavage event and to determine the
biological importance of the extracellular N-termini.
Morphological assessment of SK-N-SH cells showed that
overexpression of either untagged Gprc5b_v1 or _v2 induced an
apparent increase in neurite-like processes in comparison to
controls that expressed GFP alone (Fig. 5B–G). Similar results
were also seen in cells overexpressing flag-tagged proteins (data not
shown), suggesting that the tagging at the C-termini does not affect
the function of Gprc5b to regulate cell morphology. Quantitative
analysis confirmed visual impressions: overexpressions of
Gprc5b_v1 and Gprc5b_v2 resulted in ,3 fold (x
2=23.18;
p,0.00001) and ,4-fold (x
2=40.26; p,0.00001) increases in cells
bearing neurite-like processes, respectively, in comparison to the
cells overexpressing GFP only (a neurite-like structure is defined as
a process equal to or greater than one cell body in length) (Fig. 5H).
There was a trend of increased numbers of cells bearing neurite-
like processes in Gprc5b_v2-transfected cells as compared to
Gprc5b_v1-transfected cells (x
2=3.00; 0.1.p.0.05). The results
suggest that Gprc5b may play a role in regulation of cell
morphology, such as neurite outgrowth. It remains to be
determined whether Gprc5b_v2 plays a more potent role in
modulating neurite outgrowth than Gprc5b_v1 in vivo, and
whether brain-specific cofactors are required for fulfilling such
functions.
The flag-tagged constructs were also utilized to assess the
localization of the Gprc5b splice variants. Similar to human
Gprc5b [3], both mouse Gprc5b_v1 and Gprc5b_v2 were
transported to the plasma membrane in transfected SK-N-SH
cells (Fig. 6A–D). They were present in dynamic actin-rich
filopodia, lamelopodia, and growth cone membranes (Fig. 6E–H).
The results are consistent with the notion that Gprc5b might
regulate cytoskeletal morphology.
Discussion
We have previously described the generation and characteriza-
tion of isoform-specific p97FE65 knockout mice that are unable to
express the full-length 97 kDa FE65 protein, p97FE65 [12]. FE65
binds the intracellular tail of APP, domains of which appear to
play key roles in the pathogenesis of Alzheimer Disease [21].
While the exact function of this brain-enriched multi-modular
adaptor protein is unknown, several lines of evidence indicate that
FE65 plays a role in modulation of APP metabolism, neurite
outgrowth, neuronal positioning, and gene expression [9].
To generate knockout mice, an FE65 targeting vector was
synthesized and transfected into 129/Sv-derived R1 embryonic
stem (ES) cells, followed by injection of targeted ES cell clones into
C57Bl/6J blastocysts. After the knockout line was established,
behavioral tests were performed on F2 wild type, heterozygous,
and knockout progeny derived from mating of F1 heterozygotes
(129/Sv X C57Bl/6J). We found that p97FE65 knockout and
heterozygous mice exhibited poorer performances in comparison
to p97FE65 wild type mice in several behavioral tests that assess
hippocampus-dependent learning and memory [12].
We further characterized the learning/memory-impaired
p97FE65 null mice after they had been back crossed with
C57Bl/6J mice for ten generations. We used microarray analysis
to determine the genes potentially targeted by FE65 and possibly
involved in learning/memory. The results of the analysis led us to
discover a novel Gprc5b splice variant whose expression was
dramatically reduced in the knockouts. However, further studies
revealed that the striking difference was due to the retention of
129/Sv ES cell-derived genes neighboring the FE65 locus on
mouse chromosome 7. This appears to be one of the few published
examples of the ‘‘flanking gene problem’’ encountered in
backcross experiments using transgenically altered 129/Sv ES
cells. We show that at least one such 129/Sv-retained gene,
Gprc5b, was differentially spliced in the brains of wild type vs.
knockout animals due to strain differences in alternative splicing.
Brains of p97FE65 wild type (i.e. C57Bl/6J) mice were found to
predominantly express a previously uncharacterized splice variant,
SvJ forebrains were amplified with the same primer sets described in B. The tissues were collected from mouse pups at postnatal days 1 through 14
(P1–P14) and at three weeks (3W), and from 3 month-old (3M) adult mice. F. Quantitative analysis of expressions of Gprc5b splice variants detected in
E, as described in D. See Fig. 1A for relative positions of primers used. For B–F, Gapdh mRNA was amplified as a control. No RT: mRNA that was not
reverse transcribed to make cDNA. M: DNA markers.
doi:10.1371/journal.pone.0010351.g004
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PLoS ONE | www.plosone.org 6 April 2010 | Volume 5 | Issue 4 | e10351Figure 5. Gprc5b splice variants induce neurite-like outgrowth. A. Expression of Flag-tagged Gprc5b constructs. Human neuroblastoma (SK-
N-SH) cells were transiently transfected with untagged or C-terminal flag-tagged Gprc5b_v1 or _v2 cDNA constructs and lysed 24 hours later.
Western blotting with monoclonal Flag antibody reveals two protein bands running at ,45 kD and ,35 kD. B–G. Representative images of SK-N-SH
cells expressing green fluorescent protein (GFP) alone (B, C), or untagged Gprc5b_v1 (D, E) or _v2 (F, G) in addition to GFP. At 24 hours post-
transfection, cells were fixed for immunofluorescence analysis. Primary antibodies: GFP (green) and Gap43 (red); Hoescht DNA stain (blue). Images
were collected at 206 magnification. Scale bar =50 micrometers. H. Quantitative analysis of percentages of Gprc5b-transfected cells bearing
neurites. SK-N-SH cells were transfected with vector alone, or constructs coding for Gprc5b_v1 or _v2, as shown in B–G. A total of at least 342 GFP-
positive cells from three independent transfection experiments per condition were counted and analyzed for the presence of neurite-like processes
(which is defined as a process greater than or equal to one cell body in length). X
2-test was used to analyze statistical significance (*=p,0.00001).
The results show that overexpression of Gprc5b_v1 or _v2 increases the percentage of transfected cells (GFP-positive) bearing neurite-like processes
by ,3-fold or ,4-fold, respectively, compared to the GFP control.
doi:10.1371/journal.pone.0010351.g005
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PLoS ONE | www.plosone.org 8 April 2010 | Volume 5 | Issue 4 | e10351Gprc5b_v2, while brains of p97FE65 null mice as well as two 129/
Sv substrains, the parental strains for the F1 hybrid R1 ES cells,
were found to express a previously described variant, Gprc5b_v1.
The latter is also enriched in peripheral tissues in both C57Bl/6J
and 129/Sv mice. These results also suggest that in addition to
FE65, Gprc5b, and possibly other retained 129/Sv genes on
mouse chromosome 7 could also potentially contribute to the
phenotypes observed in p97FE65 null mice simply due to strain
differences in alternative splicing and/or additional functions
encoded within regional polymorphic genomic sequences. Al-
though we are uncertain whether the retained genes around the
FE65 locus from 129/Sv strain had confounded the learning/
memory deficits observed in p97FE65 null mice [12], it is of
interest that 129/SvEv, but not 129/SvJ mice, have been reported
to be better learners than C57Bl/6J mice in the Morris water
maze task [22]. The low expression of Gprc5b_v2 observed in at
least two 129/Sv substrains, thus, may be less likely to have been
related to the poor water maze performance found in the p97FE65
null mice [12]. More importantly, our recent experiments using
hippocampal infusions of FE65 siRNA did in fact lead to defective
learning in C57Bl/6 mice [23]. Those results support the
hypothesis that FE65 itself plays a role in hippocampal-dependent
learning and memory.
Only a few publications report on the ‘‘flanking gene problem’’
(e.g. [15,24]). Many investigators, however, have chosen to simply
ignore such caveats when formulating plans to create knockout and
transgenic mice, either due to ignorance of the existence of
recombinational ‘‘cold spots’’ or to assumptions that the risk that
strain differences encoded within the flanking genes will impact the
observed phenotypes is acceptably low. The presence of 129/Sv
genomic sequence neighboring the FE65 locus on chromosome 7
in p97FE65 null mice is not unexpected if one considers the
statistical distributions of homologous recombination. The
p97FE65 null mice used in our studies were backcrossed ten
generations, reducing the representation of 129/Sv genes in
comparison to F1 hybrid mice. However, on average, retention of
16 cM of DNA surrounding the target locus is expected even after
backcrossing 12 generations [25]. Much longer flanking gene
regions than this have been reported in some knockouts [26],
probably reflecting variations in the frequencies of recombination
along chromosomal domains. The Gprc5b gene is located
,13.3 Mb (1 Mb=,1 cM) downstream of FE65 on mouse
chromosome 7. While we did not map the total region of retention
in our mice, we did note 129/Sv-derived genomic sequences via
SNP genotyping at the rs3673791 and rs3673847 locations within
Homer2 (a member of the family proteins that regulate group 1
mGluR function) ,24 Mb upstream of the FE65 locus. Mouse
chromosome 7 is ,137 Mb in length. Assuming continuous
retention, more than 25% of mouse chromosome 7 in p97FE65
null mice may represent the genome of 129-derived ES cells.
As Gprc5b mRNA and protein are abundantly expressed in the
brain, particularly in neurons, it was of interest to compare the
expression of C-terminal splice variants Gprc5b_v1 and
Gprc5b_v2 in primary cortical neurons isolated from C57Bl/6J
pups. We found that both variants were expressed. However,
Gprc5b_v2 expression levels were elevated in more mature
neurons, suggesting that the C-terminus of this variant may play
an important role during neuronal maturation and/or in matured
neurons. The time course of the developmental expression of
Gprc5b_v2 is similar to that of proteins involved in the regulation
of synaptic plasticity, including certain mGluR splice variants and
NMDA receptor subunits [27,28]. Based on the potential role in
neurite outgrowth (Fig. 5H), the localization at membranes of
active growth (growth cones, lamelopodia and filopodia) (Fig. 6),
and the putative stimulatory effect on the actin-regulating Rho
GTPases [5], we speculate that Gprc5b_v2 is up-regulated in
mature neurons to impact the actin cytoskeleton in response to
synaptic activity, possibly influencing dendritic spine morphogen-
esis and/or plasticity [29].
Alternative splicing of proteins within the brains of higher
organisms is common, and may underlie the evolution of higher
brain function [30] as well as certain neurological diseases [31].
Many GPCRs, including the mGluR subtypes that share
homology with Gprc5b in their 7 transmembrane domains, are
alternatively spliced [32]. mGluR C-terminal splice variants differ
in signaling properties (but not G-protein coupling preferences)
[33], mechanisms of internalization [34], and subcellular locali-
zation [35]. In general, GPCR isoforms differed at the C-termini
may have distinct signaling and regulatory properties [32]. It
remains to be determined how the unique C-termini of the
Gprc5b_v1 and _v2 splice variants effect Gprc5b function in
brain. However, based on the evidence that the expression time
course of Gprc5b_v2 parallels the maturation of synapses, as
discussed above, we propose that the unique extreme C-terminus
of Gprc5b_v2 may code for a specific protein-protein interaction(s)
with a ligand(s) or a domain(s) that couples with a macromolecular
signaling complex involved in synaptic plasticity, such as the PDZ
domain-rich signaling scaffolds found at the glutamatergic synapse
[36,37].
Intriguingly, in search of unique sites of protein interaction
within the novel Gprc5b_v2 C-terminus, we noted an internal
sequence reminiscent of consensus Type I PDZ ligands (Fig. 7).
Proteins containing PDZ domains act as scaffolds to hold
together supra-molecular signaling complexes, and function in
GPCR signaling to control signaling specificity, spatial organi-
zation of the glutamatergic synapse, and receptor trafficking/
targeting [36,37]. Type I PDZ domains interact with the
consensus ligand E?S/T?X?V/I. However, divergent binding
sequences have been described [38,39]. Importantly, the
putative ligand in Gprc5b_v2, T?E?M?A?V( F i g .7 ) ,d i v e r g e s
from the consensus sequence at the -2 position. This spot is
normally held by serine or threonine, which allow for
phosphorylation-regulated binding [37]. However, we speculate
that the threonine residue residing just upstream of glutamic
acid (E) might adopt this role. While PDZ domains normally
bind the last four or five amino acids at extreme C-termini,
internal binding, often requiring the presence of a beta-finger
turn immediately adjacent to the PDZ ligand, has been reported
Figure 6. Colocalizations of Gprc5b with actin-rich membranes. A–D. SK-N-SH cells expressing flag-tagged Gprc5b_v1 (A, B) or Gprc5b_v2 (C,
D) were fixed 24 hours post-transfection, and processed for immunofluorescence analysis. Flag (green); Gap43 (red); Hoescht DNA stain (blue). Note:
Green denotes the localization of Flag-tagged Gprc5b, and not GFP, as 1) GFP is difficult to detect without primary antibody 24 hours post-
transfection, 2) GFP localization is diffuse and does not concentrate at membranes (see Fig. 6G), and 3) use of far-red secondary to detect Flag reveals
similar membrane localization (Fig. 6E). Arrows point to growth cones and lamelopodia; arrow heads point to filopodia. Images were collected at 406
magnification. Scale bar =50 micrometers. E–H. Representative SK-N-SH cell overexpressing Gprc5b_v2-flag-IRES-EGFP shows co-localizations of Flag
immunoreactivity with actin-rich membranes. (E) Flag-tagged Gprc5b_v2 (red) is concentrated at membranes. (F) F-actin (blue) is also concentrateda t
membranes. (G) Conversely, the diffuse localization of GFP (green) is seen throughout the cell body. (H) Merged images of E–G. Images were collected
at 1006magnification. Scale bar =25 micrometers.
doi:10.1371/journal.pone.0010351.g006
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following the putative PDZ interaction sequence observed in the
Gprc5b_v2 C-terminus (Fig. 7). Further proteomic studies are
required to confirm the legitimacy of this putative ligand, and to
identify the novel Gprc5b_v2 (and _v1) interacting proteins that
steer its neuronal function.
In summary, we have identified a novel C-terminal splice
variant of Gprc5b that is enriched in maturing neurons. Neuronal
GPCRs are presently targeted to treat a variety of neurological
disorders [32]. Additionally, it appears that both the brain-
enriched splice variant, Gprc5b_v2, and the ubiquitously ex-
pressed splice variant, Gprc5b_v1, might regulate processes
contributing to neurite-like outgrowth. While we recognize that
much work is still needed to confirm Gprc5b function in neurite
outgrowth, and to determine the underlying mechanism (e.g. the
involvement in Wnt signaling), the present work is the first to
present a potential function for Gprc5b in neuronal cells.
Additionally, our discovery that Gprc5b is differentially spliced
in the brains of p97FE65 null mice in comparison to their wild type
littermates due to the flanking gene problem lends further
credence to the disclaimer that any delicate and functional
phenotypes of transgenic and knockout mice that were generated
using ES cells from a different strain than the breeding strain used
to maintain the targeted mutation should be interpreted with




All animal procedures were approved by the Institutional
Animal Care and Use Committee at the University of Washington
and the National Institute of Health Guide for the Care and Use of
Laboratory animals.
RNA isolation from tissues and cultured neurons
Various tissues were dissected from p97FE65 wild-type and null
littermates (3- to 12- months of age), from post-natal (days 1–15)
and 2-month-old C57Bl/6J mice, and from post-natal (days 1–14),
3-week, 2 and 3-month-old 129X1/SvJ and/or 129S1/SvImJ
mice. Brains of 129 sub-strains were purchased from The Jackson
Laboratory (Bar Harbor, ME). Human brain (University of
Washington Medical Center autopsy number 89-055) and
peripheral tissues were previously described [41,42]. Cortical
neuron cultures were kindly provided by the laboratory of Dr.
Daniel R. Storm, University of Washington, Seattle, WA. The
neurons were isolated from the cerebral cortex of C57Bl/6J
neonates and cultured essentially as previously described [43]. The
following modifications were made to the culturing protocol: 1)
Neurons were plated onto poly-D-lysine-coated 60 mm dishes at a
density of 3610
6 cells per dish; 2) Neurobasal A media (Invitrogen,
Carlsbad, CA) was used in place of Neurobasal media; 3) 2 mM
GlutaMax (Invitrogen, Carlsbad, CA) was used in place of
0.5 mM glutamine in the culture media; and 4) no glutamate
was added to the cultures at plating. Total RNA was isolated by
homogenization of tissues or cultured cells in TRIzol (Invitrogen,
Carlsbad, CA) or RLT lysis buffer (QIAGEN, Valencia, CA),
according to the manufacturer’s instructions. Mouse brain tissues
and cells were further purified with an RNeasy mini kit (Qiagen,
Valencia, CA).
Semi-quantitative RT-PCR
Single-stranded cDNA (sscDNA) was synthesized from mRNA as
previously described [41], except that M-MLV reverse transcriptase
(RT) (Invitrogen, Carlsbad, CA) was used in place of SuperScript II.
‘‘No RT’’ controls (without addition of RT) were prepared in
parallel. The sequence information used to generate Gprc5b primers
(Fig. 1A) was obtained from Genbank accession number
NM_022420. The forward primer sequences were 1) 59-GCCTA-
CATGGAGAACAAGGC-39 (Gprc5b-A); 2) 59-GGAGCAAAGA-
TCTAGCAGCC-39 (Gprc5b-B); 3) 59-GCTGCTTTTGGAGGG-
TATGG-39 (Gprc5b-C); and 4) 59-CAAGCTGCGAGCACAAC-
TTG-39 (Gprc5b-D). The reverse primer sequences for Gprc5b
were 1) 59-ATTGAGCACGACGGCCATC-39(Gprc5b-a); 2) 59-
GGGACTTCTCAGATCTCCTG-39 (Gprc5b-b); 3) 59-CTCA-
GCTCAGATGTACTGGC-39 (Gprc5b-c); 4) 59-TGAGGCATCT-
CAGGAGGTTG-39 (Gprc5b-d); 5) 59-AGCTCCAAAGGACTC-
CAGAG-39 (Gprc5b-e); 6) 59-GTCCCAATATGGTGGCATGC-39
(Gprc5b-f); and 7) 59-GCAAGTCAGCCAGGATAAGG-39(Gprc5b-
g). The forward and reverse primer sequences for human Gapdh
were 59-CATCACCATCTTCCAGGAGCG-39 and 59-TCTCAT-
GGTTCACACCCATGACGA-39, respectively. The forward and
reverse primer sequences for beta-Actin were 59-TACAAT-
GAGCTGCGTGTGGC-39 and 59-GCCAGAGCAGTAATCTC-
CTTCT-39, respectively. PCR was performed using a Biolase DNA
Polymerase kit (Bioline USA Inc., Randolph, MA), as previously
described [41]. After initial denaturation at 94uCf o r4m i n ,c D N Aw a s
amplified using the following cycling parameters: 94uC for 30 s; 65uC
(all Gprc5b and Beta-Actin primer sets) or 60uC( G a p d h )f o r4 0s ;
72uC for 30 s (Gprc5b primer sets A/a, A/b, A/e, C/c and GAPDH),
45 s (Gprc5b primer set D/g and Beta-Actin), or 2.5 min (Gprc5b
primer sets B/d, B/f, and B/d/f). The PCR products were
electrophoresed on agarose gels containing ethidium bromide to
visualize the DNA bands.
Figure 7. Gprc5b_ _v2 contains a putative internal type I PDZ ligand (TNENMNANV, boxed) in its unique C-terminus. The consensus ligand
for type I PDZ domains is E?S/T?X?V/I (shown at the bottom). Secondary structure and beta-turn residues were predicted using the BetaTPred2
prediction program [44]. Secondary structure: C= Coil; H= Helix. Beta turn residues: t= turn preferring; n= not turn preferring.
doi:10.1371/journal.pone.0010351.g007
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The pIRES2-EGFP vector (Clontech, Mountain View, CA) was
kindly provided by Dr. Jane Sullivan, University of Washington,
Seattle, WA, with the following modifications at its multiple
cloning site: the BamHI site was removed and an EcoRV site was
introduced by PCR-based site-directed mutagenesis. The original
sequence was: gggatcc (BamHI = ggatcc); the modified sequence
is: gatatcc (EcoRV = gatatc). Gprc5b sscDNA synthesized from




AGCTCCAAAGGACTCC-39) primers containing XhoI and
EcoRI restriction sites, respectively. The PCR products were then
digested with XhoI and EcoRI restriction enzymes, and inserted at
the same cloning sites of the pIRES-EGFP vector to generate
Gprc5b_v1-IRES-EGFP and Gprc5b_v2-IRES-EGFP constructs.
Flag-tagged constructs, Gprc5b_v1-flag-IRES-EGFP and Gprc5b_
v2-flag-IRES-EGFP, were generated via site-directed mutagenesis
with a QuikChange Site-Directed Mutagenesis Kit (Stratagene, La
Jolla, CA). Two complementary oligonucleotides were used to
insert the C-terminal Flag tags (Gprc5b_v1: 59-CTCACACGG-
GAAGACACCATTGGGATTACAAGGATGACGACGATAA-







sense)). Site-directed mutagenesis was initiated with the sense and
antisense primers in separate reaction tubes. Each 20-uL reaction
consisted of 300 ng plasmid DNA template, 20 pmol primer,
250 mM dNTP, and 2.5 units PfuUltra HF DNA polymerase with
supplied reaction buffer (Stratagene, La Jolla, CA). After initial
denaturation at 95uC for 2 min, the following cycling parameters
were employed: 95uC for 1 min, 55uCf o r1 m i n ,6 8 uCf o r
12.5 min. Following 10 rounds of extension, sense and antisense
reactions were combined into one tube, and run another 12 cycles.
All inserts were verified by DNA sequencing.
Transfection and Western blotting
SK-N-SH cell cultures were maintained as previously described
[41]. Transfections were mediated by polyethylenimines (Poly-
sciences, Inc., Warrington, PA) as described previously [11]. For
each well of a 12-well plate, cells were incubated with premixed
1.2 mg DNA, 120 ml of Dulbecco’s Modified Eagle Medium, and
6 mL polyethylenimines. Amounts of the transfection reagents
were halved for cells seeded in 24-well plates. Cells were lysed in
Laemmli buffer approximately 36–48 hours after transfection.
Western blotting was performed with monoclonal anti-Flag M2
antibody (Sigma, St. Louis, MO) at 1:2000 dilutions as described
[11].
Immunocytochemistry and quantititation of SK-N-SH
cells bearing neurite-like processes
SK-N-SH cells grown on glass coverslips in 24-well plates were
fixed about 24 hrs after transfection. Immunocytochemistry was
performed essentially as described [11], except that cells were
incubated with primary antibodies for 24 hrs at 4uC. Fluoromount
G (Electron Microscopy Sciences, Hatfield, PA) was used to mount
the coverslips on slides for microscopic analysis. Flag-tagged
Gprc5b was analyzed with mouse monoclonal anti-Flag M2
antibody (Sigma, St. Louis, MO) at 1:2000 dilution, GFP with an
affinity purified rabbit polyclonal GFP antibody (Invitrogen,
Carlsbad, CA) at 1:2000 dilution, and a growth cone-associated
protein, Gap43, with a chicken polyclonal antibody against Gap43
(Abcam, Cambridge, MA) at 1:500 dilution. All secondary
antibodies (Invitrogen, Carlsbad, CA) were used at 1:400 dilutions,
which included A488 (green) donkey anti-rabbit, A594 (red) goat
anti-chicken, and A488 (green) goat anti-mouse. Following
incubation with secondary antibodies, nuclei were visualized with
the DNA-binding Hoescht dye (Invitrogen, Carlsbad, CA) at
1:20,000 dilutions for 10 min at room temperature.
Inverted coverslips were systematically sampled for GFP-
positive cells, starting at the upper left corner. Images (20x) were
acquired using a DeltaVision deconvolution microscope (Applied
Precision, Issaquah, WA), and processed using SoftWorx Explorer
Suite (Applied Precision, Issaquah, WA) and Photoshop (Adobe
Systems Incorporated, San Jose, CA). A total of at least 342 GFP-
positive cells from three independent transfection experiments per
condition were counted, and analyzed for the presence of neurite-
like processes, which were defined as processes equal to or greater
than one cell body in length.
Statistical analysis
Data were expressed as mean 6 SE. Statistical significance
between any 2 groups was determined by the 2-tailed Student t-
test or x
2-test. P values less than 0.05 were considered significant.
Database
Nucleic Acid Sequences for mouse Gprc5b_v2 (ACCESSION
FJ529379) and for human Gprc5b_v2 (ACCESSION FJ529380)
have been deposited in GenBank. All microarray data have been
deposited in GEO, the Gene Expression Omnibus Database,
under accession number GSE14274.
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